ArticleJAMA neurology2024

Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis.

Anne H Cross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.